GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 45.42K | $7.92M | n/a | n/a |
| Q2 2026 | 137 | +11 | 93.62M | $13.95B | +17 | −7 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | n/a |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | n/a | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | n/a | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | n/a |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | n/a | 24.13M | $697.01M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 6.09M | n/a | $175.97M | 0.1% | n/c | 1 | SEC ↗ ×4 |
| 2 | Wellington Management ✦ | 3.51M | n/a | $101.33M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 3 | Citadel Advisors ✦ | 3.29M | n/a | $95.04M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (pasivo) | 2.79M | n/a | $80.66M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 2.14M | n/a | $61.67M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 1.82M | n/a | $52.42M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (pasivo) | 1.38M | n/a | $39.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 1.38M | n/a | $39.73M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 814.52K | n/a | $23.52M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | ARK Investment Management ✦ | 453.59K | n/a | $13.10M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 299.80K | n/a | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 84.75K | n/a | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 66.18K | n/a | $1.91M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 20.20K | n/a | $583,405 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 481 tenedores, 137.05M acciones, $11.53B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 69 acc. · $11,032
Director · 116 acc. · $20,300
Director · 826 acc. · $144,550
Director · 1.10K acc. · $192,432
Director · 3.30K acc. · $578,888
Director · 1.30K acc. · $229,236
Director · 971 acc. · $172,330
Officer · 7.74K acc. · $1.38M
Officer · 4.00K acc. · $632,193
Officer, Director · 7.59K acc. · $1.29M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología